Safety
pruritus
ADVERSE EVENT
Rates of AEs were similar across treatment groups. Overall, 85.5% of patients experienced at least 1 AE (Table Occurrence of AEs during the study and TEAEs with ≥10% incidence, by preferred term
Abbreviations: AE, adverse event; CVC, cenicriviroc; N, number of participants in group; n, number of participants with outcome; SAE, serious AE; TEAE, treatment-emergent AE; TXRThe proportion of patients who experienced pruritus was the highest in the TXROverall, 21 of 193 patients (10.9%) discontinued from study treatment due to an AE, with most discontinuations occurring in the TXRThe AEs that attributed to the most discontinuations from study treatment were pruritus [TXR